US$ 24.77
icer glp 1 Incremental cost-effectiveness ratio (ICER) scatterplot comparing newer GLP-1 drugs for obesity now
Description
But you shouldnt be required to cover it just because your insurer is telling you to. The policy change comes at a time when the rising cost of prescription drugs, including Alzheimers medicines and targeted cancer therapies, has become a pressing issue for state and federal policy makers
What the FDA documented here is alarming on its own terms

Final Thoughts: Should You Consider GLP-1s

Both are sold by Danish drug giant Novo Nordisk